CoChat

p53 attenuates AKT signaling by modulating membrane phospholipid composition

Open access
Rueda-Rincon, Natalia, Bloch, Katarzyna, Derua, Rita, Vyas, Rajesh, Harms, Amy, Hankemeier, Thomas, Khan, Niamat Ali, Dehairs, Jonas, Bagadi, Muralidhararao, Binda, Maria Mercedes, Waelkens, Etienne, Marine, Jean-Christophe, Swinnen, Johannes V. · 2015 · Oncotarget
Cited by 46

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

// Natalia Rueda-Rincon 1 , Katarzyna Bloch 1 , Rita Derua 2 , Rajesh Vyas 3, 4 , Amy Harms 5, 6 , Thomas Hankemeier 5, 6 , Niamat Ali Khan 1 , Jonas Dehairs 1 , Muralidhararao Bagadi 1 , Maria Mercedes Binda 7 , Etienne Waelkens 2 , Jean-Christophe Marine 3, 4 , Johannes V. Swinnen 1 1 KU Leuven - University of Leuven, Department of Oncology, Laboratory of Lipid Metabolism and Cancer, Leuven, Belgium 2 KU Leuven - University of Leuven, Department of Cellular and Molecular Medicine, Laboratory of Protein Phosphorylation and Proteomics, Leuven, Belgium 3 KU Leuven - University of Leuven, Center for the Biology of Disease, Laboratory for Molecular Cancer Biology, VIB, Leuven, Belgium 4 KU Leuven - University of Leuven, Department of Human Genetics, Laboratory for Molecular Cancer Biology, VIB, Leuven, Belgium 5 Division of Analytical Biosciences, Leiden Academic Centre for Drug Research, Leiden University, The Netherlands 6 Netherlands Metabolomics Centre, Leiden, The Netherlands 7 Institut de Recherche Expérimentale et Clinique (IREC), Pôle de Gynécologie, Bruxelles, Belgium Correspondence to: Johannes V. Swinnen, e-mail: johan.swinnen@med.kuleuven.be Keywords: p53, SCD, SREBP, phospholipids, cancer Received: February 03, 2015 Accepted: May 21, 2015 Published: June 03, 2015 ABSTRACT The p53 tumor suppressor is the central component of a complex network of signaling pathways that protect organisms against the propagation of cells carrying oncogenic mutations. Here we report a previously unrecognized role of p53 in membrane phospholipids composition. By repressing the expression of stearoyl-CoA desaturase 1, SCD, the enzyme that converts saturated to mono-unsaturated fatty acids, p53 causes a shift in the content of phospholipids with mono-unsaturated acyl chains towards more saturated phospholipid species, particularly of the phosphatidylinositol headgroup class. This shift affects levels of phosphatidylinositol phosphates, attenuates the oncogenic AKT pathway, and contributes to the p53-mediated control of cell survival. These findings expand the p53 network to phospholipid metabolism and uncover a new molecular pathway connecting p53 to AKT signaling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.4067

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 40

  1. Crawford, 1979, T antigen is bound to a host protein in SV40-transformed cells, Nature, 278, 261, 10.1038/278261a0 · DOI · Paper page
  2. Levine, 1979, Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells, Cell, 17, 43, 10.1016/0092-8674(79)90293-9 · DOI · Paper page
  3. Levine, 2000, Surfing the p53 network, Nature, 408, 307, 10.1038/35042675 · DOI · Paper page
  4. Vousden, 2013, Metabolic regulation by p53 family members, Cell Metab, 18, 617, 10.1016/j.cmet.2013.06.019 · DOI · Paper page
  5. Vousden, 2010, p53 regulation of metabolic pathways, Cold Spring Harb Perspect Biol, 2, a001040
  6. Feng, 2013, The regulation of cellular metabolism by tumor suppressor p53, Cell & bioscience, 3, 9, 10.1186/2045-3701-3-9 · DOI · Paper page
  7. Lindblom, 2007, Domain formation in model membranes studied by pulsed-field gradient-NMR: the role of lipid polyunsaturation, Biophys J, 93, 3182, 10.1529/biophysj.107.111534 · DOI · Paper page
  8. Feigenson, 2008, Membrane lipids: where they are and how they behave, Nature reviews Molecular cell biology, 9, 112, 10.1038/nrm2330 · DOI · Paper page
  9. Damjanovich, 2003, Dynamic, yet structured: The cell membrane three decades after the Singer-Nicolson model, Proc Natl Acad Sci U S A, 100, 8053, 10.1073/pnas.1332550100 · DOI · Paper page
  10. Verhoeven, 2006, Increased lipogenesis in cancer cells: new players, novel targets, Current opinion in clinical nutrition and metabolic care, 9, 358, 10.1097/01.mco.0000232894.28674.30 · DOI · Paper page
  11. Ferber, 2013, Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth, Cancer & metabolism, 1, 3, 10.1186/2049-3002-1-3 · DOI · Paper page
  12. Chung, 2012, Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells, Molecular cancer research : MCR, 10, 133, 10.1158/1541-7786.MCR-11-0206 · DOI · Paper page
  13. Munck, 2010, De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation, Cancer Res, 70, 8117, 10.1158/0008-5472.CAN-09-3871 · DOI · Paper page
  14. York, 2013, An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity, Cancer Res, 73, 2850, 10.1158/0008-5472.CAN-13-0382-T · DOI · Paper page
  15. Shyy, 2004, Vascular endothelial growth factor activation of sterol regulatory element binding protein: a potential role in angiogenesis, Circulation research, 95, 471, 10.1161/01.RES.0000139956.42923.4A · DOI · Paper page
  16. Schimmer, 2011, Inhibition of SREBP1 sensitizes cells to death ligands, Oncotarget, 2, 186, 10.18632/oncotarget.239 · DOI
  17. Agarwal, 2014, Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1, Oncotarget, 5, 10017, 10.18632/oncotarget.2488 · DOI
  18. Liu, 2004, activation of the p53 pathway by small-molecule antagonists of MDM2, Science, 303, 844, 10.1126/science.1092472 · DOI · Paper page
  19. Perry, 2003, mdm2 Is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation, Mol Cell Biol, 23, 462, 10.1128/MCB.23.2.462-473.2003 · DOI · Paper page
  20. Ntambi, 2009, Biochemical and physiological function of stearoyl-CoA desaturase, Am J Physiol Endocrinol Metab, 297, E28, 10.1152/ajpendo.90897.2008 · DOI · Paper page
  21. Nakagawa, 2003, p53 Activation in adipocytes of obese mice, J Biol Chem, 278, 25395, 10.1074/jbc.M302364200 · DOI · Paper page
  22. Espinosa, 2014, Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms, eLife, 3, e02200, 10.7554/eLife.02200 · DOI · Paper page
  23. Snyder, 2012, An integrated encyclopedia of DNA elements in the human genome, Nature, 489, 57, 10.1038/nature11247 · DOI · Paper page
  24. Igal, 2008, Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis, International journal of oncology, 33, 839
  25. McGraw, 2009, The Akt kinases: isoform specificity in metabolism and cancer, Cell Cycle, 8, 2502, 10.4161/cc.8.16.9335 · DOI · Paper page
  26. Epand, 2012, Phosphatidylinositol-4-phosphate 5-kinase isoforms exhibit acyl chain selectivity for both substrate and lipid activator, J Biol Chem, 287, 35953, 10.1074/jbc.M112.370155 · DOI · Paper page
  27. Rassidakis, 2007, Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma, Clin Cancer Res, 13, 3380, 10.1158/1078-0432.CCR-06-2581 · DOI · Paper page
  28. Hosoi, 2009, Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells, Clin Cancer Res, 15, 4077, 10.1158/1078-0432.CCR-08-2955 · DOI · Paper page
  29. Horton, 1998, Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver, J Biol Chem, 273, 35299, 10.1074/jbc.273.52.35299 · DOI · Paper page
  30. Edwards, 1999, Identification of conserved cis-elements and transcription factors required for sterol-regulated transcription of stearoyl-CoA desaturase 1 and 2, J Biol Chem, 274, 20603, 10.1074/jbc.274.29.20603 · DOI · Paper page
  31. Aaronson, 2014, p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes, Oncogene, 33, 3959, 10.1038/onc.2013.378 · DOI · Paper page
  32. Avances, 2010, Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice, Molecular cancer therapeutics, 9, 1740, 10.1158/1535-7163.MCT-09-1064 · DOI · Paper page
  33. Copland, 2013, Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma, Clin Cancer Res, 19, 2368, 10.1158/1078-0432.CCR-12-3249 · DOI · Paper page
  34. Igal, 2011, Roles of StearoylCoA Desaturase-1 in the Regulation of Cancer Cell Growth, Survival and Tumorigenesis, Cancers, 3, 2462, 10.3390/cancers3022462 · DOI
  35. Rialland, 2010, Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells, PLoS One, 5, e14363, 10.1371/journal.pone.0014363 · DOI
  36. Testa, 2005, Perturbations of the AKT signaling pathway in human cancer, Oncogene, 24, 7455, 10.1038/sj.onc.1209085 · DOI · Paper page
  37. Oren, 2002, Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis, Oncogene, 21, 1299, 10.1038/sj.onc.1205181 · DOI · Paper page
  38. Mak, 2001, Regulation of PTEN transcription by p53, Mol Cell, 8, 317, 10.1016/S1097-2765(01)00323-9 · DOI · Paper page
  39. Qing, 2012, FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth, Cancer Res, 72, 5843, 10.1158/0008-5472.CAN-12-1329 · DOI
  40. Vreeken, 2014, Enhanced lipid isomer separation in human plasma using reversed-phase UPLC with ion-mobility/high-resolution MS detection, J Lipid Res, 55, 1772, 10.1194/jlr.D047795 · DOI

Cited by

See all 46

Metadata

Authors
Rueda-Rincon, N., Bloch, K., Derua, R., Vyas, R., Harms, A., Hankemeier, T., Khan, N. A., Dehairs, J., Bagadi, M., Binda, M. M., Waelkens, E., Marine, J.-C., & Swinnen, J. V.
Venue
Oncotarget
Published
2015-06-03
Volume
6
Issue
25
Pages
21240-21254
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1552458787
Cited by
46
References
12
FWCI
2.19
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.